Dr. Philip S. Low is the Presidential Scholar for Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry at Purdue University. Dr. Low has spent over >45 years exploring: 1) targeted therapeutic and imaging agents for multiple human diseases (including cancers, autoimmune, infectious, and inflammatory diseases), and 2) the structure, function, and pathologies of the erythrocyte membrane, He has published >450 scientific articles and has >100 US patents/patents pending. Eight drugs stemming from his research are currently undergoing human clinical trials and seven companies (Endocyte Inc., OnTarget Laboratories Inc., Umoja Biopharma, Morphimmune Inc., Novosteo Inc., Eradivir Inc. and ErythroCure Inc.) have been founded to commercialize these discoveries. Dr. Low received his B.S. in Chemistry from BYU (1971) and his Ph.D. in Biochemistry from UCSD (1975).
Research Keywords & Expertise
drug discovery and dev...
fluorescence guided su...
Erythrocyte membrane s...
Ligand-targeted therap...
Reprogramming of the i...
Fingerprints
5%
Reprogramming of the immune system
5%
fluorescence guided surgery
5%
drug discovery and development
5%
Erythrocyte membrane structure, function and pathologies
5%
Ligand-targeted therapeutic and imaging agents
Short Biography
Dr. Philip S. Low is the Presidential Scholar for Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry at Purdue University. Dr. Low has spent over >45 years exploring: 1) targeted therapeutic and imaging agents for multiple human diseases (including cancers, autoimmune, infectious, and inflammatory diseases), and 2) the structure, function, and pathologies of the erythrocyte membrane, He has published >450 scientific articles and has >100 US patents/patents pending. Eight drugs stemming from his research are currently undergoing human clinical trials and seven companies (Endocyte Inc., OnTarget Laboratories Inc., Umoja Biopharma, Morphimmune Inc., Novosteo Inc., Eradivir Inc. and ErythroCure Inc.) have been founded to commercialize these discoveries. Dr. Low received his B.S. in Chemistry from BYU (1971) and his Ph.D. in Biochemistry from UCSD (1975).
Well done!
